Sort
78,016 grants matching “breast cancer”
(PQ9) Characterization and prophylactic treatment of chemotherapy-induced long-term adverse sequelae
$560,277Roland Jurecic · University Of Miami School Of Medicine · R01 · FY2017 · CA
(PQ9) Characterization and prophylactic treatment of chemotherapy-induced long-term adverse sequelae
$560,277Roland Jurecic · University Of Miami School Of Medicine · R01 · FY2018 · CA
(PQ9) Characterization and prophylactic treatment of chemotherapy-induced long-term adverse sequelae
$560,277Roland Jurecic · University Of Miami School Of Medicine · R01 · FY2020 · CA
Role of metalloproteinases in mammary gland remodeling
$560,252Zena Werb · University Of California, San Francisco · R01 · FY2008 · CA
The Genetics of Susceptibility to Mouse Plasma Cell Tumors
$560,222Beverly Mock · Division Of Basic Sciences - Nci · ZIA · FY2019 · CA
Imaging and Targeting Metastatic-Prone Breast Cancer
$560,220Ronald G Blasberg · Sloan-Kettering Inst Can Research · R01 · FY2017 · CA
INFRASRUCTURE SUPPORT AND DATA ENHANCEMENTS FOR THE CARET BIOREPOSITORY
$560,214Gary E Goodman · Fred Hutchinson Cancer Research Center · UM1 · FY2014 · CA
Reproductive and Developmental Toxicity of Dioxin
$560,190Richard E Peterson · University Of Wisconsin-Madison · R01 · FY2011 · ES
Multifunctional Photosensitizers for Image-guided PDT of Brain Tumors
$560,188Ravindra K Pandey · Roswell Park Cancer Institute Corp · R01 · FY2012 · CA
New Century Breast Cancer Diagnostics System
$560,186Shih-Chung B Lo · Georgetown University · R33 · FY2007 · CA
HER2-targeting transformable nanotherapeutic platform against HER2+ cancers
$560,183Kit S Lam · University Of California At Davis · R01 · FY2023 · CA
ALPHA2-ADRENERGIC RECEPTORS AND BREAST TUMOR STROMA: A NOVEL PATHWAY DRIVING BREAST CANCER GROWTH AND METASTASIS
$560,148University Of Rochester · · FY2013 · Department of Defense
Metropolitan New York Regisry of Breast Cancer Families
$560,142Mary Beth Terry · Columbia University Health Sciences · U01 · FY2010 · CA
(PQ9) The role of Bclw (bcl2l2) in preventing chemotherapy induced neuropathy
$560,138Rosalind A Segal · Dana-Farber Cancer Inst · R01 · FY2019 · CA
Cherokee Nation Health Analytics Core (CNHAC) Capacity Building Project
$560,121Amanda E Janitz · Cherokee Nation · S06 · FY2017 · GM
Racial/Ethnic and SES Disparities in Quality of Breast Cancer Systemic Therapy
$560,091Jennifer J Griggs · University Of Michigan At Ann Arbor · R01 · FY2009 · CA
Navigation from Community to Clinic to promote CRC Screening in Underserved Popul
$560,038Linda K Larkey · Arizona State University-Tempe Campus · R01 · FY2015 · CA
Point-of-care cellular and molecular pathology of breast tumors on a cell phone
$560,028Ashutosh Chilkoti · Duke University · R01 · FY2024 · CA
The IGF Signaling Pathway and Breast Cancer Risk
$560,026Susan L. Neuhausen · University Of California-Irvine · R01 · FY2007 · CA
Luteal Adjuvant Oophorectomy in Vietnamese Breast Cancer
$560,016Richard Reed Love · Ohio State University · R01 · FY2006 · CA
Transcriptome-wide association study to identify susceptibility genes for colorectal cancer
$559,998Xingyi Guo · Vanderbilt University Medical Center · R37 · FY2021 · CA
Occupational and Environmental Determinants of Cancer among Women and Minorities
$559,959Laura Beane Freeman · Division Of Cancer Epidemiology And Genetics · ZIA · FY2014 · CA
Predictive Modeling of the EGFR-MAPK pathway for Triple Negative Breast Cancer Patients
$559,954Charles M Perou · Univ Of North Carolina Chapel Hill · U01 · FY2022 · CA
Disparities in Breast Cancer: Development and Survival in Hispanic and NHW Women
$559,897Martha Or Marty L Slattery · University Of Utah · R01 · FY2013 · CA
The role of the BRCA1 and BRCA2 gene in the pathogenesis of breast cancer
$559,896Lawrence Brody · Human Genome Research · Z01 · FY2007 · HG